Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -110.78M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 23,600
Avg Vol 30,360
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 64%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It...

Phone: 919 313 9633
Address:
2525 East North Carolina Highway 54, Durham, United States
Latest News on HUMAW
Humacyte price target lowered to $1.25 from $1.50 at TD Cowen

2026-06-17T12:32:32.000Z - 17 days ago

Humacyte price target lowered to $1.25 from $1.50 at TD Cowen


Humacyte Slides: Corporate presentation

Jun 16, 2026, 3:00 PM EDT - 18 days ago

Humacyte Slides: Corporate presentation


Humacyte Transcript: Study result

Jun 15, 2026, 5:00 PM EDT - 19 days ago

Humacyte Transcript: Study result


Humacyte Press release: Study result

Jun 15, 2026, 5:00 PM EDT - 19 days ago

Humacyte Press release: Study result


Humacyte price target raised to $4 from $3 at H.C. Wainwright

2026-06-11T13:47:07.000Z - 23 days ago

Humacyte price target raised to $4 from $3 at H.C. Wainwright


Humacyte 47.62M share Spot Secondary priced at $1.05

2026-06-11T01:35:07.000Z - 24 days ago

Humacyte 47.62M share Spot Secondary priced at $1.05


Humacyte TBA Spot Secondary; price range $1.05-$1.15

2026-06-10T22:15:08.000Z - 24 days ago

Humacyte TBA Spot Secondary; price range $1.05-$1.15


Humacyte announces V012 study of ATEV meets primary endpoint

2026-06-10T20:14:24.000Z - 24 days ago

Humacyte announces V012 study of ATEV meets primary endpoint


Humacyte announces common stock offering, no amount given

2026-06-10T20:10:11.000Z - 24 days ago

Humacyte announces common stock offering, no amount given


Humacyte Transcript: AGM 2026

Jun 9, 2026, 8:00 AM EDT - 25 days ago

Humacyte Transcript: AGM 2026


Humacyte price target raised to $2 from $1 at Benchmark

2026-06-01T11:58:24.000Z - 4 weeks ago

Humacyte price target raised to $2 from $1 at Benchmark


Humacyte price target raised to $1.50 from $1 at TD Cowen

2026-05-14T15:08:47.000Z - 7 weeks ago

Humacyte price target raised to $1.50 from $1 at TD Cowen


Humacyte reports Q1 EPS (9c), consensus (12c)

2026-05-13T13:00:50.000Z - 7 weeks ago

Humacyte reports Q1 EPS (9c), consensus (12c)


Humacyte Earnings Call Transcript: Q1 2026

May 13, 2026, 8:00 AM EDT - 7 weeks ago

Humacyte Earnings Call Transcript: Q1 2026


Humacyte Earnings release: Q1 2026

May 13, 2026, 8:00 AM EDT - 7 weeks ago

Humacyte Earnings release: Q1 2026


Humacyte Quarterly report: Q1 2026

May 13, 2026, 8:00 AM EDT - 7 weeks ago

Humacyte Quarterly report: Q1 2026


Humacyte names Todd Rasmussen chief surgical officer

2026-05-12T15:32:56.000Z - 7 weeks ago

Humacyte names Todd Rasmussen chief surgical officer


Humacyte Transcript: KOL event

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Humacyte Transcript: KOL event


Humacyte Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Humacyte Proxy statement: Proxy filing


Humacyte Appoints Jim Mercadante as Chief Commercial Officer

Apr 22, 2026, 8:00 AM EDT - 2 months ago

Humacyte Appoints Jim Mercadante as Chief Commercial Officer


Humacyte Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

Humacyte Proxy statement: Proxy filing


Humacyte price target lowered to $1.50 from $3.50 at Barclays

2026-04-08T09:30:25.000Z - 3 months ago

Humacyte price target lowered to $1.50 from $3.50 at Barclays


Humacyte downgraded to Speculative Buy from Buy at Benchmark

2026-03-31T13:30:42.000Z - 3 months ago

Humacyte downgraded to Speculative Buy from Buy at Benchmark


Humacyte Earnings Call Transcript: Q4 2025

Mar 27, 2026, 8:00 AM EDT - 3 months ago

Humacyte Earnings Call Transcript: Q4 2025


Humacyte Annual report: Q4 2025

Mar 27, 2026, 8:00 AM EDT - 3 months ago

Humacyte Annual report: Q4 2025


Humacyte Earnings release: Q4 2025

Mar 27, 2026, 8:00 AM EDT - 3 months ago

Humacyte Earnings release: Q4 2025


Humacyte Transcript: TD Cowen 46th Annual Health Care Conference

Mar 4, 2026, 10:30 AM EST - 4 months ago

Humacyte Transcript: TD Cowen 46th Annual Health Care Conference


Humacyte To Participate in Upcoming Investor Conferences

Mar 2, 2026, 8:00 AM EST - 4 months ago

Humacyte To Participate in Upcoming Investor Conferences


Humacyte Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:00 AM EST - 8 months ago

Humacyte Earnings Call Transcript: Q3 2025


Humacyte Quarterly report: Q3 2025

Nov 12, 2025, 8:00 AM EST - 8 months ago

Humacyte Quarterly report: Q3 2025


Humacyte Earnings release: Q3 2025

Nov 12, 2025, 8:00 AM EST - 8 months ago

Humacyte Earnings release: Q3 2025


Humacyte Registration statement: Registration Filing

Sep 12, 2025, 8:00 AM EDT - 10 months ago

Humacyte Registration statement: Registration Filing


Humacyte Earnings Call Transcript: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 11 months ago

Humacyte Earnings Call Transcript: Q2 2025


Humacyte Quarterly report: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 11 months ago

Humacyte Quarterly report: Q2 2025


Humacyte Earnings release: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 11 months ago

Humacyte Earnings release: Q2 2025


Humacyte Earnings Call Transcript: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

Humacyte Earnings Call Transcript: Q1 2025


Humacyte Quarterly report: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

Humacyte Quarterly report: Q1 2025


Humacyte Earnings release: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

Humacyte Earnings release: Q1 2025


Humacyte Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Humacyte Proxy statement: Proxy Filing


Humacyte Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Humacyte Proxy statement: Proxy Filing


Humacyte Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Humacyte Proxy statement: Proxy Filing


Humacyte Earnings Call Transcript: Q4 2024

Mar 28, 2025, 8:30 AM EDT - 1 year ago

Humacyte Earnings Call Transcript: Q4 2024


Humacyte Annual report: Q4 2024

Mar 28, 2025, 8:30 AM EDT - 1 year ago

Humacyte Annual report: Q4 2024


Humacyte Earnings release: Q4 2024

Mar 28, 2025, 8:30 AM EDT - 1 year ago

Humacyte Earnings release: Q4 2024